SK channels as antiarrhythmic targets for atrial fibrillation: structural and pharmacological perspectives
American Journal of Physiology-Cell Physiology · 01.06.2026 · 330 (6) · C1597-C1604
DOI: 10.1152/ajpcell.00921.2025 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Physiology-Cell Physiology, erschienen am 01.06.2026. Verfasst von Megan K McKie und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Atrial Fibrillation, Small-Conductance Calcium-Activated Potassium Channels, Anti-Arrhythmia Agents, Heart Atria. Die Arbeit nennt 62 Literaturangaben. Gefördert von: EC | Horizon Europe | Excellent Science | HORIZON EUROPE Marie Sklodowska-Curie Actions (MSCA), Novo Nordisk Fonden (NNF).
Abstract (Originalsprache)
Small-conductance Ca 2+ -activated K + (SK) channels have emerged as promising atrial-selective targets for rhythm control in atrial fibrillation (AF). Genetic association studies, functional experiments, and early clinical trials collectively support a role for SK channels in atrial repolarization and AF maintenance. Recent breakthroughs in single-particle cryo-electron microscopy have provided high-resolution structures of the SK2 channel, revealing unique architectural features that underlie its low conductance and susceptibility to pharmacological modulation. Numerous studies have shown alterations in SK transcript abundance in AF in both humans and animal models. However, recent functional studies have demonstrated dynamic regulation of SK channel gating and membrane trafficking in AF, highlighting context-dependent pro- and antiarrhythmic effects. This mini review summarizes the recent structural and functional advances in our understanding of SK channels and emerging therapeutic implications for AF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.
ORCID-Profile: Luca Soattin, Bo Hjorth Bentzen
Förderung
- EC | Horizon Europe | Excellent Science | HORIZON EUROPE Marie Sklodowska-Curie Actions (MSCA)
- Novo Nordisk Fonden (NNF)
Zitieren
APA
McKie, M. K., Meibom, E. H., Ramirez, A. G., Soattin, L., & Bentzen, B. H. (2026). SK channels as antiarrhythmic targets for atrial fibrillation: structural and pharmacological perspectives. American Journal of Physiology-Cell Physiology, 330(6), C1597-C1604. https://doi.org/10.1152/ajpcell.00921.2025
Vancouver
McKie MK, Meibom EH, Ramirez AG, Soattin L, Bentzen BH. SK channels as antiarrhythmic targets for atrial fibrillation: structural and pharmacological perspectives. American Journal of Physiology-Cell Physiology. 2026;330(6):C1597-C1604. doi:10.1152/ajpcell.00921.2025
BibTeX
@article{McKie2026,
author = {McKie, Megan K and Meibom, Emma H and Ramirez, Andreina Gil and Soattin, Luca and Bentzen, Bo Hjorth},
title = {SK channels as antiarrhythmic targets for atrial fibrillation: structural and pharmacological perspectives},
journal = {American Journal of Physiology-Cell Physiology},
year = {2026},
volume = {330},
number = {6},
pages = {C1597--C1604},
doi = {10.1152/ajpcell.00921.2025}
}
EUVIMED